Alcon Terminates Agreement to Acquire STAAR Surgical, Looks to Product Launches in 2026

NEWARK, N.J.—Alcon (SIX/NYSE: ALC), a global leader in eyecare, announced on Tuesday night the termination of its definitive merger agreement with STAAR Surgical Company (NASDAQ: STAA). The move followed a STAAR shareholder vote held early on Tuesday that failed to produce sufficient support for the proposed merger, valued at approximately $1.6 billion, as reported yesterday in VMAIL. Prior to Alcon’s announcement Tuesday night, STAAR advised in a separate news release that morning that it would be terminating the merger agreement, noting that no termination fee would be payable by either party and that STAAR will remain a stand-alone, publicly traded company.